 |
|
|
| |
Impact of Bulevirtide Given With or Without Nucleos(t)ide Analogues
on 48-Week Virologic Outcomes in Patients With Chronic Hepatitis Delta Virus Infection
|
| |
| |
European Association for the Study of the Liver; 05-08 June 2024; Milan, Italy
Pietro Lampertico1,2, Maurizia Brunetto3,4, Maria Buti5,6, Soo Aleman7, Pavel Bogomolov8, Vladimir Chulanov9, Nina Mamonova10, Viacheslav Morozov11, Olga Sagalova12, Tatyana Stepanova13,
John F Flaherty14, Mingyang Li14, Dmitry Manuilov14, Ben L Da14, Renee-Claude Mercier14, Grace M Chee14, Markus Cornberg15, Heiner Wedemeyer15, Tarik Asselah16
|
| |
|
|
|
|
|
